89
|
330
|
7cweA |
Human fructose-1,6-bisphosphatase 1 in apo r-state |
101
|
327
|
7cvhA |
Human fructose-1,6-bisphosphatase 1 in complex with geranylgeranyl diphosphate |
106
|
327
|
7c9qA |
Crystal structure of human liver fructose-1,6-bisphoaphatase complex with mg2+ and amp |
0
|
3
|
7ns3Fb |
Substrate receptor scaffolding module of yeast chelator-gid sr4 e3 ubiquitin ligase bound to fbp1 substrate |
105
|
330
|
7ns5A |
Structure of yeast fbp1 (fructose-1,6-bisphosphatase 1) |
104
|
334
|
7k74A |
Crystal structure of fructose-1,6-bisphosphatase, type i, from stenotrophomonas maltophilia k279a |
98
|
327
|
6lw2A |
The n-arylsulfonyl-indole-2-carboxamide-based inhibitors against fructose-1,6-bisphosphatase |
110
|
327
|
6ls5A |
Structure of human liver fbpase complexed with covalent allosteric inhibitor |
109
|
327
|
5pzzA |
Human liver fructose-1,6-bisphosphatase 1 (fructose 1,6-bisphosphate 1-phosphatase, e.c.3.1.3.11) complexed with the allosteric inhibitor 1-(5-bromo-1,3-thiazol-2-yl)-3-(3,4-dichlorophenyl)sulfonylurea |
94
|
327
|
5pztA |
Human liver fructose-1,6-bisphosphatase 1 (fructose 1,6-bisphosphate 1-phosphatase, e.c.3.1.3.11) complexed with the allosteric inhibitor 1-(5-bromo-1,3-thiazol-2-yl)-3-(3-ethyl-4-phenylphenyl)sulfonylurea |
107
|
327
|
5q05A |
Human liver fructose-1,6-bisphosphatase 1 (fructose 1,6-bisphosphate 1-phosphatase, e.c.3.1.3.11) complexed with the allosteric inhibitor 1-(5-bromo-1,3-thiazol-2-yl)-3-[5-(2-methoxyethyl)-4-methylthiophen-2-yl]sulfonylurea |
106
|
327
|
5q08A |
Human liver fructose-1,6-bisphosphatase 1 (fructose 1,6-bisphosphate 1-phosphatase, e.c.3.1.3.11) complexed with the allosteric inhibitor 1-(1-benzothiophen-3-ylsulfonyl)-3-(5-bromo-1,3-thiazol-2-yl)urea |
105
|
327
|
5pzuA |
Human liver fructose-1,6-bisphosphatase 1 (fructose 1,6-bisphosphate 1-phosphatase, e.c.3.1.3.11) complexed with the allosteric inhibitor [5-[2-amino-5-(2-methylpropyl)-1,3-thiazol-4-yl]furan-2-yl]phosphonic acid |
106
|
327
|
5q09A |
Human liver fructose-1,6-bisphosphatase 1 (fructose 1,6-bisphosphate 1-phosphatase, e.c.3.1.3.11) complexed with the allosteric inhibitor 1-[4-bromo-6-(carbamoylamino)pyridin-2-yl]-3-[5-(2-methoxyethyl)-4-methylthiophen-2-yl]sulfonylurea |
100
|
327
|
5q04A |
Human liver fructose-1,6-bisphosphatase 1 (fructose 1,6-bisphosphate 1-phosphatase, e.c.3.1.3.11) complexed with the allosteric inhibitor 1-(4-bromo-5-chlorothiophen-2-yl)sulfonyl-3-(5-bromo-1,3-thiazol-2-yl)urea |
102
|
327
|
5pzxA |
Human liver fructose-1,6-bisphosphatase 1 (fructose 1,6-bisphosphate 1-phosphatase, e.c.3.1.3.11) complexed with the allosteric inhibitor 1-(5-bromo-1,3-thiazol-2-yl)-3-[4-methoxy-3-(2-methylpropyl)phenyl]sulfonylurea |
102
|
327
|
5pzrA |
Human liver fructose-1,6-bisphosphatase 1 (fructose 1,6-bisphosphate 1-phosphatase, e.c.3.1.3.11) complexed with the allosteric inhibitor 1-(3-chlorophenyl)sulfonyl-3-[3-[3-[(3-chlorophenyl)sulfonylcarbamoylamino]propoxy]propyl]urea |
105
|
327
|
5q07A |
Human liver fructose-1,6-bisphosphatase 1 (fructose 1,6-bisphosphate 1-phosphatase, e.c.3.1.3.11) complexed with the allosteric inhibitor 1-(4-bromo-6-morpholin-4-ylpyridin-2-yl)-3-[5-(2-methoxyethyl)-4-methylthiophen-2-yl]sulfonylurea |
105
|
327
|
5q0aA |
Human liver fructose-1,6-bisphosphatase 1 (fructose 1,6-bisphosphate 1-phosphatase, e.c.3.1.3.11) complexed with the allosteric inhibitor 1-(5-cyanopyrazin-2-yl)-3-[3-(difluoromethoxy)phenyl]sulfonylurea |
101
|
327
|
5q01A |
Human liver fructose-1,6-bisphosphatase 1 (fructose 1,6-bisphosphate 1-phosphatase, e.c.3.1.3.11) complexed with the allosteric inhibitor 1-(5-bromo-1,3-thiazol-2-yl)-3-[4-(4,5-dichloro-2-methylpyrazol-3-yl)oxyphenyl]sulfonylurea |
109
|
327
|
5q00A |
Human liver fructose-1,6-bisphosphatase 1 (fructose 1,6-bisphosphate 1-phosphatase, e.c.3.1.3.11) complexed with the allosteric inhibitor 2-[3-[(5-bromo-1,3-thiazol-2-yl)carbamoylsulfamoyl]-1-methylindol-7-yl]oxyacetamide |
102
|
327
|
5pzsA |
Human liver fructose-1,6-bisphosphatase 1 (fructose 1,6-bisphosphate 1-phosphatase, e.c.3.1.3.11) complexed with the allosteric inhibitor 1-(3-chlorophenyl)sulfonyl-3-[6-[(3-chlorophenyl)sulfonylcarbamoylamino]hexyl]urea |
110
|
328
|
5q0cA |
Human liver fructose-1,6-bisphosphatase 1 (fructose 1,6-bisphosphate 1-phosphatase, e.c.3.1.3.11) complexed with the allosteric inhibitor 1-(5-bromo-1,3-thiazol-2-yl)-3-[5-(4-methoxyphenyl)thiophen-2-yl]sulfonylurea and with fructose-2,6-diphosphate |
109
|
327
|
5q0bA |
Human liver fructose-1,6-bisphosphatase 1 (fructose 1,6-bisphosphate 1-phosphatase, e.c.3.1.3.11) complexed with the allosteric inhibitor 1-(4-bromo-3-methyl-1,2-thiazol-5-yl)-3-(3-methylphenyl)sulfonylurea |
104
|
327
|
5pzwA |
Human liver fructose-1,6-bisphosphatase 1 (fructose 1,6-bisphosphate 1-phosphatase, e.c.3.1.3.11) complexed with the allosteric inhibitor 1-(3-chlorophenyl)sulfonyl-3-[5-[(3-chlorophenyl)sulfonylcarbamoylamino]pentyl]urea |
105
|
327
|
5pzyA |
Human liver fructose-1,6-bisphosphatase 1 (fructose 1,6-bisphosphate 1-phosphatase, e.c.3.1.3.11) complexed with the allosteric inhibitor 1-(5-bromo-1,3-thiazol-2-yl)-3-(2-chlorophenyl)sulfonylurea |
104
|
327
|
5pzvA |
Human liver fructose-1,6-bisphosphatase 1 (fructose 1,6-bisphosphate 1-phosphatase, e.c.3.1.3.11) complexed with the allosteric inhibitor 1-(4-bromopyridin-2-yl)-3-(4-chlorophenyl)sulfonylurea |
100
|
327
|
5pzqA |
Human liver fructose-1,6-bisphosphatase 1 (fructose 1,6-bisphosphate 1-phosphatase, e.c.3.1.3.11) complexed with the allosteric inhibitor 2-(4-methoxyphenyl)furan-3,4-dicarboxylic acid |
105
|
327
|
5q06A |
Human liver fructose-1,6-bisphosphatase 1 (fructose 1,6-bisphosphate 1-phosphatase, e.c.3.1.3.11) complexed with the allosteric inhibitor 1-(5-bromo-1,3-thiazol-2-yl)-3-[4-(2-methyl-1,3-thiazol-4-yl)phenyl]sulfonylurea |
102
|
327
|
5q03A |
Human liver fructose-1,6-bisphosphatase 1 (fructose 1,6-bisphosphate 1-phosphatase, e.c.3.1.3.11) complexed with the allosteric inhibitor 1-(5-bromo-1,3-thiazol-2-yl)-3-[5-(2-methylpropyl)thiophen-2-yl]sulfonylurea |
106
|
327
|
5q02A |
Human liver fructose-1,6-bisphosphatase 1 (fructose 1,6-bisphosphate 1-phosphatase, e.c.3.1.3.11) complexed with the allosteric inhibitor 1-(5-bromo-1,3-thiazol-2-yl)-3-[5-(1,2-oxazol-3-yl)thiophen-2-yl]sulfonylurea |
100
|
331
|
5ldzA |
Quadruple space group ambiguity due to rotational and translational non-crystallographic symmetry in human liver fructose-1,6-bisphosphatase |
84
|
326
|
5l0aA |
Human muscle fructose-1,6-bisphosphatase e69q mutant in active r-state in complex with fructose-1,6-bisphosphate |
79
|
326
|
5k56A |
Human muscle fructose-1,6-bisphosphatase in active r-state in complex with fructose-1,6-bisphosphate |
81
|
325
|
5k54A |
Human muscle fructose-1,6-bisphosphatase e69q mutant in active r-state |
80
|
252
|
6b65A |
Impase (af2372) r92q/k164e |
98
|
312
|
6ayyA |
Crystal structure of apo fructose-1,6-bisphosphatase from mycobacterium tuberculosis |
86
|
252
|
6b63A |
Impase (af2372) with 25 mm asp |
85
|
252
|
6b61A |
Impase (af2372) with 25 mm asp |
85
|
252
|
6b62A |
Impase (af2372) with 400 mm glutamate |
87
|
252
|
6b64A |
Impase (af2372) with 25 mm asp |
88
|
252
|
6b5zA |
Impase (af2372) with 25 mm asp |
99
|
319
|
6ayvA |
Crystal structure of fructose-1,6-bisphosphatase t84a from mycobacterium tuberculosis |
97
|
319
|
6ayuA |
Crystal structure of fructose-1,6-bisphosphatase t84s from mycobacterium tuberculosis |
88
|
252
|
6b66A |
Impase (af2372) r92q/k164e with 400 mm glutamate |
83
|
252
|
6b60A |
Impase (af2372) with 25 mm glutamate |
100
|
330
|
5fbpA |
Crystal structure of the neutral form of fructose-1,6-bisphosphatase complexed with the product fructose 6-phosphate at 2.1-angstroms resolution |
111
|
338
|
5a5lA |
Structure of dual function fbpase sbpase from thermosynechococcus elongatus |
119
|
389
|
3t2eA |
Fructose-1,6-bisphosphate aldolase/phosphatase from thermoproteus neutrophilus, f6p-bound form |
124
|
390
|
3t2dA |
Fructose-1,6-bisphosphate aldolase/phosphatase from thermoproteus neutrophilus, fbp-bound form |